These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4695480)

  • 1. Pharmacology of carbenicillin indanyl sodium in renal insufficiency.
    Cox CE
    J Infect Dis; 1973 May; 127():Suppl:156-62. PubMed ID: 4695480
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of an indanyl ester of carbenicillin.
    Wallace JF; Atlas E; Bear DM; Brown NK; Clark H; Turck M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():223-6. PubMed ID: 5521341
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbenicillin indanyl sodium, an orally active derivative of carbenicillin.
    English AR; Retsema JA; Ray VA; Lynch JE
    Antimicrob Agents Chemother; 1972 Mar; 1(3):185-91. PubMed ID: 4558137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of carbenicillin indanyl sodium, ampicillin, and cephaloglycin in treatment of urinary-tract infection.
    Ries KM; Cobbs GC; Gillenwater JY; Levison ME; Mandell GL; Kaye D
    J Infect Dis; 1973 May; 127():Suppl:148-53. PubMed ID: 4695479
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of difficult urinary-tract infections with carbenicillin indanyl sodium.
    Baker DA; Andriole VT
    J Infect Dis; 1973 May; 127():Suppl:136-42. PubMed ID: 4714084
    [No Abstract]   [Full Text] [Related]  

  • 6. Indanyl carbenicillin in the treatment of chronic urinary tract infection.
    Queiroz FP; Rocha H
    Rev Bras Pesqui Med Biol; 1974; 7(4):369-72. PubMed ID: 4431984
    [No Abstract]   [Full Text] [Related]  

  • 7. Indanyl carbenicillin in chronic recurrent urinary tract infections.
    Seneca H
    J Urol; 1973 Aug; 110(2):249-51. PubMed ID: 4578984
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind comparison of carbenicillin indanyl sodium, ampicillin, and cephalexin in treatment of urinary tract infection.
    Ries KM; Cobbs CG; Gillenwater JY; Levison ME; Mandell GL; Sande MA; Kaye D
    Antimicrob Agents Chemother; 1973 Dec; 4(6):593-6. PubMed ID: 4602827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic urinary tract infections. Remission rates with trimethoprim and-or sulfamethoxazole or indanyl carbenicillin.
    Seneca H; Zinsser HH; Uson A
    N Y State J Med; 1974 Mar; 74(3):494-8. PubMed ID: 4594911
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term oral carbenicillin therapy in complicated urinary-tract infections.
    Holloway WJ; Taylor WA
    J Infect Dis; 1973 May; 127():Suppl:143-5 p. PubMed ID: 4576799
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical-pharmacological study of the new semi-synthetic penicillin preparation, carbenicillin, in urologic patients. Relations between blood and tissue concentration of carbenicillin].
    Iván E; Földi J; Arr M; Molnár I; Biró L
    Z Urol Nephrol; 1970 Apr; 63(4):241-6. PubMed ID: 4943703
    [No Abstract]   [Full Text] [Related]  

  • 12. Human pharmacology and clinical evaluation of an oral carbenicillin preparation.
    Bran JL; Karl DM; Kaye D
    Clin Pharmacol Ther; 1971; 12(3):525-30. PubMed ID: 5208911
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics, toleration, and safety of indanyl carbenicillin in man.
    Knirsch AK; Hobbs DC; Korst JJ
    J Infect Dis; 1973 May; 127():Suppl:105-10. PubMed ID: 4695476
    [No Abstract]   [Full Text] [Related]  

  • 14. Ambulatory treatment of chronic urinary-tract infections in elderly males: a comparative study of three oral antibiotics.
    Westenfelder M; Madsen PO
    J Infect Dis; 1973 May; 127():Suppl:154-6 p. PubMed ID: 4714085
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mezlocillin and carbenicillin in urinary tract infections in patients after kidney transplantation].
    Prát V; Hatala M; Horcicková M; Matousovic K
    Cas Lek Cesk; 1983 Jun; 122(22):679-81. PubMed ID: 6223701
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of indanyl carbenicillin by dogs, rats, and humans.
    Hobbs DC
    Antimicrob Agents Chemother; 1972 Oct; 2(4):272-5. PubMed ID: 4670499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of an oral form of carbenicillin in patients with renal failure.
    Bailey RR; Eastwood JB; Vaughan RB
    Postgrad Med J; 1972 Jul; 48(561):422-6. PubMed ID: 5069898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbenicillin therapy in renal failure.
    Johny M; Derrington AW; Lawrence JR; Clapp KH
    Med J Aust; 1969 Oct; 2(14):681-4. PubMed ID: 5348652
    [No Abstract]   [Full Text] [Related]  

  • 19. Indanyl carbenicillin: chemistry and laboratory studies with a new semisynthetic penicillin.
    Butler K; English AR; Briggs B; Gralla E; Stebbins RB; Hobbs DC
    J Infect Dis; 1973 May; 127():Suppl:97-104. PubMed ID: 4571995
    [No Abstract]   [Full Text] [Related]  

  • 20. [Carbenicillin in the treatment of urinary infections].
    Comeri G; Passera R; Bortoluzzi E
    Minerva Med; 1971 Apr; 62(32):1658-68. PubMed ID: 5577297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.